Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P46108
UPID:
CRK_HUMAN
Alternative names:
Proto-oncogene c-Crk; p38
Alternative UPACC:
P46108; A8MWE8; B0LPE8; D3DTH6; Q96GA9; Q96HJ0
Background:
The Adapter molecule crk, also known as Proto-oncogene c-Crk and p38, plays a pivotal role in cellular processes such as branching, adhesion, and motility. It is central to the BCAR1-CRK-RAPGEF1 signaling pathway, leading to RAP1 activation. Furthermore, it regulates cell adhesion and migration through MAPK8 activation and interacts with DOCK1 and DOCK4 to mediate phagocytosis of apoptotic cells and cell motility.
Therapeutic significance:
Understanding the role of Adapter molecule crk could open doors to potential therapeutic strategies.